drugset / Trial / NCT02427529

Muscle-Sparing Effect Of Human Chorionic Gonadotropin (hCG) During a Very Low Calorie Diet (VLCD)

NCT02427529

Phase 1/2 Completed 59 enrolled Dr. Emma's Corporation
RandomizedParallel-groupDouble-blindTreatment

Summary

Subjects are female patients, randomized to HCG group or placebo group, during a prospective trial, in order to determine the significance, if any, of HCG on maintaining muscle mass during a very low calorie diet in order to demonstrate the potential significance of HCG administration on preserving lean body mass while losing weight.

Timeline

Start
2011-05
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject human chorionic gonadotropin Protein / enzyme biologic 200 iu Subcutaneous
Subject human chorionic gonadotropin Protein / enzyme biologic 300 iu Subcutaneous

Indications

No indication recorded.